Recombinant Human ALK-1 (C-Fc)(Cat. No.:C422) novoprotein

$30.00
In stock
SKU
C422
10μg: $30 50μg: $90 500μg: $600 1mg: $950

Description

Recombinant Human Activin Receptor-Like Kinase 1 is produced by our Mammalian expression system and the target gene encoding Asp22-Gln118 is expressed with a human IgG1 Fc tag at the C-terminus.

Product Details

ItemDetails
Known AsSerine/Threonine-Protein Kinase Receptor R3; SKR3; Activin Receptor-Like Kinase 1; ALK-1; TGF-B Superfamily Receptor Type I; TSR-I; ACVRL1; ACVRLK1; ALK1
Mol Mass37.6 KDa
APMol Mass50-65 KDa, reducing conditions
Formulation DescriptionLyophilized from a 0.2 μm filtered solution of PBS, pH 7.4.
Endotoxin< 1 EU/µg as determined by LAL test.
ReconstitutionAlways centrifuge tubes before opening.Do not mix by vortex or pipetting.
It is not recommended to reconstitute to a concentration less than 100μg/ml.
Dissolve the lyophilized protein in distilled water.
Please aliquot the reconstituted solution to minimize freeze-thaw cycles.
StorageLyophilized protein should be stored at ≤ -20°C, stable for one year after receipt.
Reconstituted protein solution can be stored at 2-8°C for 2-7 days.
Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months.
ShippingThe product is shipped at ambient temperature.
Upon receipt, store it immediately at the temperature listed below.

Background

Activin Receptor-Like Kinase 1 (ALK-1) is a type I cell-surface receptor for the TGF-βsuperfamily of ligands. ALK-1 has a high degree of similarity in serine-threonine kinase subdomains, a glycine and serine rich region preceding the kinase-domain, and a C-terminal tail with other activin receptor-like kinase proteins. The mutations of ALK-1 are associated with Rendu-Osler-Weber syndrome 2, this suggests ACVRL1 is associated with blood vessel development and repair.

MDSD

Datasheet

Reviews

Write Your Own Review
You're reviewing:Recombinant Human ALK-1 (C-Fc)(Cat. No.:C422) novoprotein
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.